Literature DB >> 3954470

2',5'-oligoadenylate synthetase induction in lymphocytes of patients with connective tissue diseases.

W Hylton, J Cayley, C Dore, A M Denman.   

Abstract

Spontaneous production of the interferon induced enzyme 2',5'-oligoadenylate synthetase (2',5'-A synthetase) was significantly greater in blood lymphocytes of patients with systemic lupus erythematosus (SLE), Behçet's syndrome, and rheumatoid arthritis than in control lymphocytes. Alpha interferon (IFN-alpha) induced comparable production of enzyme in normal, rheumatoid, and Behçet's lymphocytes, and reduced, but still appreciable amounts in SLE lymphocytes. Phytohaemagglutinin (PHA) did not induce enzyme. Thus spontaneous production of 2',5'-A synthetase is encountered in several connective tissue diseases and seems likely to be induced by in-vivo exposure to interferons.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3954470      PMCID: PMC1001854          DOI: 10.1136/ard.45.3.220

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  11 in total

1.  Synthesis of 2'5'-oligo(A) in extracts of interferon-treated HeLa cells.

Authors:  M A Minks; S Benvin; P A Maroney; C Baglioni
Journal:  J Biol Chem       Date:  1979-06-25       Impact factor: 5.157

2.  Behçet's syndrome with arthritis.

Authors:  R M Mason; C G Barnes
Journal:  Ann Rheum Dis       Date:  1969-03       Impact factor: 19.103

3.  Synthesis of low molecular weight inhibitor of protein synthesis with enzyme from interferon-treated cells.

Authors:  A G Hovanessian; R E Brown; I M Kerr
Journal:  Nature       Date:  1977-08-11       Impact factor: 49.962

4.  Clinical value of the determination of an interferon-induced enzyme activity: studies of the 2'5' oligoadenylate synthetase activity in peripheral blood lymphocytes of patients.

Authors:  S Chousterman; M Chousterman; P Reinert; M N Thang
Journal:  Biomed Pharmacother       Date:  1983       Impact factor: 6.529

5.  Enzyme markers for the presence of circulating interferon: 2-5A synthetase in blood lymphocytes and protein kinase in platelet-rich plasma.

Authors:  C Buffet-Janvresse; A G Hovanessian
Journal:  Proc Soc Exp Biol Med       Date:  1984-02

6.  Multiple interferons in the circulation of patients with systemic lupus erythematosus and vasculitis.

Authors:  J J Hooks; G W Jordan; T Cupps; H M Moutsopoulos; A S Fauci; A L Notkins
Journal:  Arthritis Rheum       Date:  1982-04

7.  Intensive immunosuppression versus prednisolone in the treatment of connective tissue diseases.

Authors:  P Hollingworth; A de Vere Tyndall; B M Ansell; T Platts-Mills; J M Gumpel; J Mertin; D S Smith; A M Denman
Journal:  Ann Rheum Dis       Date:  1982-12       Impact factor: 19.103

8.  Interferon-gamma production by peripheral blood mononuclear cells from patients with Behçet's syndrome.

Authors:  T H Bacon; F Ozbakir; C A Elms; A M Denman
Journal:  Clin Exp Immunol       Date:  1984-09       Impact factor: 4.330

9.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

10.  Assay of an interferon-induced enzyme in white blood cells as a diagnostic aid in viral diseases.

Authors:  A Schattner; D Wallach; G Merlin; T Hahn; S Levin; M Revel
Journal:  Lancet       Date:  1981-09-05       Impact factor: 79.321

View more
  4 in total

Review 1.  Herpes simplex virus and the rheumatic diseases.

Authors:  A M Denman; B K Pelton; W Hylton; R G Palmer; R Topper
Journal:  Rheumatol Int       Date:  1989       Impact factor: 2.631

2.  Natural killer cell activity, interferon-gamma and antibodies to herpes viruses in patients with Behçet's disease.

Authors:  K Hamzaoui; K Ayed; A Slim; M Hamza; J Touraine
Journal:  Clin Exp Immunol       Date:  1990-01       Impact factor: 4.330

3.  CD4 and CD8 cell responses to herpes simplex virus in Behçet's disease.

Authors:  C Young; T Lehner; C G Barnes
Journal:  Clin Exp Immunol       Date:  1988-07       Impact factor: 4.330

4.  Microarray analysis of mercury-induced changes in gene expression in human liver carcinoma (HepG2) cells: importance in immune responses.

Authors:  Wellington K Ayensu; Paul B Tchounwou
Journal:  Int J Environ Res Public Health       Date:  2006-06       Impact factor: 3.390

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.